ConductScience.org, home

Paper40928697

Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis.

Wang Y and 2 others. Curr Rheumatol Rep, 2025. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis. Papers, record 40928697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40928697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advances in Drug Research Targeting Neutrophils for the Treatment of Rheumatoid Arthritis.
PubMed
Journal
Curr Rheumatol Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-05
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang YYiRan
2Shu YYiQin
3Wu HHao

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Arthritis, RheumatoidMajor topic
Antirheumatic AgentsMajor topic
NeutrophilsMajor topic
Extracellular TrapsMajor topic
Humans
Biological Products
Drugs, Chinese Herbal

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No.KYZZ202502The Hubei Enshi College School-level Key Scientific Research ProjectPubMed
No.81960776The National Natural Science Foundation of ChinaPubMed
No.2023AFD069The Natural Science Foundation of Hubei ProvincePubMed
No.D20230022The Technical support projects of Enshi Tujia and Miao Autonomous Prefecture Science and Technology BureauPubMed

Source PubMed

Download CSV of grants

References83

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131767647Neutrophil Extracellular Traps in Host Defense.Cold Spring Harb Perspect Biol2020https://conductscience.org/library/papers/31767647PubMed
235173870Traditional Chinese medicine together with high-dose vitamin C improves the therapeutic effect of western medicine against COVID-19.Am J Transl Res2022https://conductscience.org/library/papers/35173870PubMed
337938773Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes.Nature2023https://conductscience.org/library/papers/37938773PubMed
433117162Potential Advantages of Bioactive Compounds Extracted From Traditional Chinese Medicine to Inhibit Bone Destructions in Rheumatoid Arthritis.Front Pharmacol2020https://conductscience.org/library/papers/33117162PubMed
539221253The emerging role of neutrophil extracellular traps in the progression of rheumatoid arthritis.Front Immunol2024https://conductscience.org/library/papers/39221253PubMed
638576269Neutrophil extracellular trap formation and its implications in nonsteroidal anti-inflammatory drug-induced small intestinal injury.J Gastroenterol Hepatol2024https://conductscience.org/library/papers/38576269PubMed
740076593Neutrophils: Linking Inflammation to Thrombosis and Unlocking New Treatment Horizons.Int J Mol Sci2025https://conductscience.org/library/papers/40076593PubMed
822980329Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis.Cell Host Microbe2012https://conductscience.org/library/papers/22980329PubMed
924860732Anti-inflammatory and Antimicrobial Effects of Heat-Clearing Chinese Herbs: A Current Review.J Tradit Complement Med2014https://conductscience.org/library/papers/24860732PubMed
1036132145Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis.Front Oncol2022https://conductscience.org/library/papers/36132145PubMed
1139701217Systematic insight into the dual COX-2/5-LOX inhibitory mechanism of Duhuo Jisheng decoction for treatment of osteoarthritis based on in silico and bioassay.J Ethnopharmacol2025https://conductscience.org/library/papers/39701217PubMed
1239300084Neutrophil extracellular traps in homeostasis and disease.Signal Transduct Target Ther2024https://conductscience.org/library/papers/39300084PubMed
1321639923A traditional Chinese medicine versus Western combination therapy in the treatment of rheumatoid arthritis: two-stage study protocol for a randomized controlled trial.Trials2011https://conductscience.org/library/papers/21639923PubMed
1438812134[Optimization and verification of conditions for induction of neutrophil extracellular traps in vitro].Zhongguo Zhong Yao Za Zhi2024https://conductscience.org/library/papers/38812134PubMed
1532253838Use of Tripterygium wilfordii Hook F for immune-mediated inflammatory diseases: progress and future prospects.J Zhejiang Univ Sci B2020https://conductscience.org/library/papers/32253838PubMed
1633519474Clinical Practice Guideline for Tripterygium Glycosides/Tripterygium wilfordii Tablets in the Treatment of Rheumatoid Arthritis.Front Pharmacol2020https://conductscience.org/library/papers/33519474PubMed
1739105461Neutrophil extracellular traps: Potential targets for the treatment of rheumatoid arthritis with traditional Chinese medicine and natural products.Phytother Res2024https://conductscience.org/library/papers/39105461PubMed
1840371029Quality-by-Design (QbD) Assisted Synthesis of Nanoparticle for Efficient Loading, Stabilization, and Intracellular Delivery of Bioactive for the Treatment of Arthritis.Indian J Microbiol2025https://conductscience.org/library/papers/40371029PubMed
1927643663Therapeutic potential of Oroxylin A in rheumatoid arthritis.Int Immunopharmacol2016https://conductscience.org/library/papers/27643663PubMed
2039226727Targeting neutrophils extracellular traps, a promising anti-thrombotic therapy for natural products from traditional Chinese herbal medicine.Biomed Pharmacother2024https://conductscience.org/library/papers/39226727PubMed

See all 83 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41993209Association between neutrophil-to-lymphocyte ratio and the prognosis of patients with rheumatoid arthritis: a meta-analysis.Front Immunol2026https://conductscience.org/library/papers/41993209

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40928697

GET https://conductscience.org/api/papers/v1/40928697/references?page=2